Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse event
Clinical management of congenital hyperinsulinism (CHI) remains a significant challenge due to its complex pathophysiology and the limitations of available therapies. Dasiglucagon, a synthetic glucagon analog, represents a novel approach to managing CHI, particularly in patients where conventional t...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Bioscientifica
2025-04-01
|
| Серія: | Endocrinology, Diabetes & Metabolism Case Reports |
| Предмети: | |
| Онлайн доступ: | https://edm.bioscientifica.com/view/journals/edm/2025/2/EDM-25-0006.xml |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|